Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents
Clinical trial NCT05030675 · COMPLETED
Trial details
- NCT number
- NCT05030675
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-13
- Primary completion
- 2024-08-08
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.